Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Product Development in Life Science
Chapter 3 Market Dynamics
- Global Market Dynamics
- Market Drivers
- Increasing Investments in R&D
- Increasing Prevalence of Chronic Diseases
- Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
- Growth in Genomic and Biomarker Research
- Increasing Demand for Personalized Medicine
- Technological Advances
- Market Restraints
- End of COVID-19 Pandemic
- High Cost of Instruments
- Lack of Skilled Personnel
- Market Challenges
- Market Opportunities
- Positive Impact from Some Revisions in Pharmaceutical Legislation
- New Technologies
Chapter 4 Emerging Technologies and Developments
- Overview
- Next-Generation Therapeutics
- Next-Generation Diagnostics
- Digitalization
- AI and Machine Learning
- Internet of Things (IoT)
- Robots in Life Science Labs
Chapter 5 Market Segmentation Analysis
- Overview
- Segmentation Breakdown
- European Market for Life Science Tools and Diagnostics, by Product Type
- COVID-19 Diagnostic Tests Market
- Market for Life Science Tools and Reagents
- European Market for Life Science Tools and Diagnostics, by Application
- Genomics
- Proteomics
- Cell Biology, Antibodies and Recombinant Proteins
- Stem Cells Research
- Imaging Tools and Techniques
- Animal Models
- Epigenetics
- Metabolomics
- Other Applications
- European Market for Life Science Tools and Diagnostics, by Country
- United Kingdom
- Germany
- France
- Switzerland
- Spain
- Italy
- Rest of Europe
Chapter 6 Competitive Intelligence
- PCR Technologies and Reagents
- Antibodies
- ELISA Instruments
- ELISA Kits and Assays
- Life Science Kits and Assays
- COVID-19 Diagnostics
- Strategic Initiatives
- Recent Product Introductions in the Market
Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective
- Introduction to ESG
- ESG Practices in the Industry
- Status of ESG in the Industry
- Concluding Remarks
List of Tables
Summary Table: European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 1: Differences Between Basic and Applied Research
Table 2: Pharmaceutical Industry R&D Expenditures in Europe, by Select Countries, 2022
Table 3: Cancer Cases in Europe for Both Sexes, 2022
Table 4: European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, Through 2029
Table 5: European Market for COVID-19 Diagnostics Tests, by Type, Through 2029
Table 6: European Market for COVID-19 Molecular Tests, by Country, Through 2029
Table 7: European Market for COVID-19 Antigen Tests, by Country, Through 2029
Table 8: European Market for COVID-19 Serological Tests, by Country, Through 2029
Table 9: European Market for Life Science Tools and Reagents, by Type, Through 2029
Table 10: European Market for Life Science Instruments, by Country, Through 2029
Table 11: European Market for Life Science Reagents and Kits, by Country, Through 2029
Table 12: European Market for Life Science Tools and Reagents, by Application, Through 2029
Table 13: European Market for Genomics, by Country, Through 2029
Table 14: Drug Targets Identified by Proteomics
Table 15: European Market for Proteomics, by Country, Through 2029
Table 16: European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029
Table 17: European Market for Stem Cell Research, by Country, Through 2029
Table 18: European Market for Imaging Tools and Techniques, by Country, Through 2029
Table 19: European Market for Animal Models, by Country, Through 2029
Table 20: European Market for Epigenetics, by Country, Through 2029
Table 21: European Market for Metabolomics, by Country, Through 2029
Table 22: European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029
Table 23: European Based Companies’ R&D Expenditures and Comparison of Their Net Sales, 2023
Table 24: European Market for Life Science Tools and Reagents, by Country, Through 2029
Table 25: European Market for Life Science COVID-19 Diagnostics Tests, by Country, Through 2029
Table 26: Ranking of Life Science Tool and Reagent Companies in Europe, 2023
Table 27: Leading Providers of PCR Technologies, by Revenue, 2023
Table 28: Leading Suppliers of Research Antibodies, 2023
Table 29: Leading Providers of ELISA Instruments/Microplate Readers, 2023
Table 30: Leading Providers of ELISA Kits and Assays, 2023
Table 31: Ranking of Leading Suppliers of Kits and Assays, 2023
Table 32: Ranking of Leading Providers of COVID-19 Diagnostics Tools, 2023
Table 33: Collaborations in the Life Science Tools and Reagents Market, 2020-2024
Table 34: Mergers and Acquisitions in the Life Science Tools and Reagents Market, 2021-2024
Table 35: Recent New Life Science Tools and Reagents, 2021-2024
Table 36: Key Focus Areas in ESG Metrics
Table 37: Environmental Initiatives by Various Life Science Tools, Reagents and Diagnostics Companies and Some of their Initiatives in Europe
Table 38: Key Social and Governance Issues in the Life Science Tools, Reagents and Diagnostics Industry
Table 39: ESG Rankings for Companies in the Life Science Tools and Reagents Market, 2023
Table 40: Glossary of Terms Used in This Report
Table 41: Information Sources in This Report
Table 42: Agilent Technologies Inc.: Company Snapshot
Table 43: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44: Agilent Technologies Inc.: Product Portfolio
Table 45: Agilent Technologies Inc.: News/Key Developments, 2023
Table 46: Altona Diagnostic GmbH.: Company Snapshot
Table 47: Altona Diagnostic GmbH: Product Portfolio
Table 48: Altona Diagnostic GmbH: News/Key Developments, 2021-2023
Table 49: Analytik Jena GmbH+Co KG: Company Snapshot
Table 50: Analytik Jena GmbH+Co KG: Product Portfolio
Table 51: Analytik Jena GmbH+Co KG: News/Key Developments, 2023
Table 52: BD: Company Snapshot
Table 53: BD: Financial Performance, FY 2022 and 2023
Table 54: BD: Product Portfolio
Table 55: BD: News/Key Developments, 2021-2024
Table 56: Bio-Rad Laboratories Inc.: Company Snapshot
Table 57: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58: Bio-Rad Laboratories Inc.: Product Portfolio
Table 59: Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023
Table 60: Danaher Corp.: Company Snapshot
Table 61: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 62: Danaher Corp.: Product Portfolio
Table 63: Danaher Corp.: News/Key Developments, 2021-2023
Table 64: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 65: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 66: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 67: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2023
Table 68: Merck KGaA: Company Snapshot
Table 69: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 70: Merck KGaA.: Product Portfolio
Table 71: Merck KGaA: News/Key Developments, 2021-2024
Table 72: Promega Corp.: Company Snapshot
Table 73: Promega Corp.: Product Portfolio
Table 74: Promega Corp.: News/Key Developments, 2023 and 2024
Table 75: Qiagen: Company Snapshot
Table 76: Qiagen: Financial Performance, FY 2022 and 2023
Table 77: Qiagen: Product Portfolio
Table 78: Qiagen: News/Key Developments, 2023
Table 79: Revvity Inc.: Company Snapshot
Table 80: Revvity Inc.: Financial Performance, FY 2022 and 2023
Table 81: Revvity Inc.: Product Portfolio
Table 82: Revvity Inc.: News/Key Developments, 2023 and 2024
Table 83: Thermo Fisher Scientific Inc.: Company Snapshot
Table 84: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 85: Thermo Fisher Scientific Inc.: Product Portfolio
Table 86: Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024
List of Figures
Summary Figure: European Market for Life Science Tools and COVID-19 Diagnostics, by Product Type, 2021-2029
Figure 1: Market Dynamics of European Life Science Tools and Reagents Market
Figure 2: New Diagnostic Techniques
Figure 3: Comparison of New Active Substances Approvals
Figure 4: Comparison of European Patent Applications and Granted Patents, by Technical Field, 2011-2022
Figure 5: European Market Shares of COVID-19 Diagnostics Tests, by Type, 2023
Figure 6: European Market Shares of Life Science Tools and Reagents, by Type, 2023
Figure 7: Types of ELISA
Figure 8: Firms and R&D Investment in Health Industries, 2012 and 2022
Figure 9: Pharmaceutical Pipeline Activity and Key Therapeutic Areas in Europe, 2022
Figure 10: The U.K. Market for Life Science Tools and Reagents, 2024-2029
Figure 11: German Market for Life Science Tools and Reagents, 2021-2029
Figure 12: French Market for Life Science Tools and Reagents, 2021-2029
Figure 13: Swiss Market for Life Science Tools and Reagents, 2024-2029
Figure 14: Spanish Market for Life Science Tools and Reagents, 2024-2029
Figure 15: Italian Market for Life Science Tools and Reagents, 2021-2029
Figure 16: Rest of the European Market for Life Science Tools and Reagents, 2021-2029
Figure 17: EPFIA’s Environmental Sustainability Measures
Figure 18: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 19: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 20: BD: Revenue Share, by Business Unit, FY 2023
Figure 21: BD: Revenue Share, by Country/Region, FY 2023
Figure 22: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 27: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 28: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 29: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 30: Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 31: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 32: Revvity Inc.: Revenue Share, by Business Unit, FY 2023
Figure 33: Revvity Inc.: Revenue Share, by Country/Region, FY 2023
Figure 34: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
